The Increased Risk of Skin Cancer Is Persistent After Discontinuation of Psoralen+Ultraviolet A: A Cohort Study
Top Cited Papers
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 121 (2) , 252-258
- https://doi.org/10.1046/j.1523-1747.2003.12350.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996Journal of the American Academy of Dermatology, 2001
- Psoriasis, its Treatment, and Cancer in a Cohort of Finnish PatientsJournal of Investigative Dermatology, 2000
- Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimensJournal of the American Academy of Dermatology, 1999
- Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: The role of molecular epidemiology in minimizing risksEnvironmental and Molecular Mutagenesis, 1998
- Ways of measuring rates of recurrent eventsBMJ, 1996
- PUVA and skin cancerJournal of the American Academy of Dermatology, 1992
- Relation between Skin Cancer and HLA Antigens in Renal-Transplant RecipientsNew England Journal of Medicine, 1991
- Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiationFundamental and Applied Toxicology, 1991
- "High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancerBritish Journal of Dermatology, 1991
- Skin cancer in patients with chronic radiation dermatitisJournal of the American Academy of Dermatology, 1989